The drug’s manufacturer, will charge $141,000 for the first 12 weeks of treatment and $256,000 for a year of treatment, according to the Wall Street Journal. Experts fear the cost of the drug could keep some patients from receiving what could be the best care available.
When calculating the average cost for one extra year of life, the researchers determined patients and insurers paid $54,100 in 1995. The price for one year of life increased to $139,100 in 2005 and $207,000 in 2013.
Healthcare costs for treatment of life-threatening disease are unsustainable. Consumers need “stop-loss” coverage as their highest priority.
Norb Leahy, Dunwoody GA Tea Party Leader